MilliporeSigma Acquires Mirus Bio for $600 Million, Enhancing Viral Vector Manufacturing Capabilities

Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...

August 02, 2024 | Friday | News
Molecure and Avicenna Biosciences Announce Strategic Collaboration to Develop Novel Cancer Therapies Targeting USP7

Molecure S.A. (‘Molecure’, SWE Ticker: MOC) and Avicenna Biosciences, Inc. announced today that they have entered into a strategic research c...

August 01, 2024 | Thursday | News
AbCellera Expands Collaboration with Eli Lilly to Develop Therapeutic Antibodies Across Multiple Therapeutic Areas

AbCellera (Nasdaq: ABCL) announcedthat it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies f...

August 01, 2024 | Thursday | News
Biogen, Beckman Coulter, and Fujirebio Announce Collaboration to Develop Blood Biomarkers for Alzheimer's Disease

The collaboration aims to identify and develop accessible and mini-invasive blood biomarkers specific to tau pathology in the brain These tools ...

July 31, 2024 | Wednesday | News
Nexcella Secures $8 Million CIRM Grant to Advance CAR-T Therapy for AL Amyloidosis

Nexcella, Inc.  a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced tha...

July 26, 2024 | Friday | News
Triastek and BioNTech Partner to Develop Innovative Oral RNA Therapeutics Using 3D Printing Technology

Triastek Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals,  announced that it has entered into a research collaboration and platfor...

July 25, 2024 | Thursday | News
GeneCentric Therapeutics Secures AMA PLA Code for AI-Driven PurIST Pancreatic Cancer Test

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that the American Medical Assoc...

July 25, 2024 | Thursday | News
Pfizer Announces Positive Results from Phase 3 Study of Investigational Gene Therapy for Hemophilia A

Pfizer Inc. announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gen...

July 24, 2024 | Wednesday | News
Varian Receives FDA Clearance for Enhanced Ethos 2.0 Therapy System, Streamlining Adaptive Radiotherapy

Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new functionality to its ...

July 23, 2024 | Tuesday | News
GC Cell and Lukas Biomedical Forge Strategic International Partnership

 GC Cell Corporation (hereinafter referred to as "GC Cell"; 144510:KOSDAQ) and Lukas Biomedical Co., Ltd. (hereinafter referred to as "Lukas," TWSE ...

July 22, 2024 | Monday | News
Innovent Biologics Announces Phase 3 Success for Mazdutide in Treating Type 2 Diabetes

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of on...

July 22, 2024 | Monday | News
Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...

July 19, 2024 | Friday | News
GC Cell and Checkpoint Therapeutics Announce Collaboration to Explore Synergistic Cancer Therapies

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell thera...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close